In obesity, dietary n-3 PUFA supplementation has been shown to reduce AT CLS formation, reduce macrophage AT infiltration by reducing MCP-1 tissue expression and improve the inflammatory secretory profile, in part, by increasing adiponectin [27,28]. This evidence concerns the gene CCL2 and obesity due to melanocortin 4 receptor deficiency.